|
Q1 FY2027
As of Sep 30, 2026
|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Jun 30, 2022
|
Q4 FY2021
As of Jun 30, 2021
|
Q4 FY2020
As of Jun 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current assets | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable, net | |||||||||||||||||
| Prepaid expenses | |||||||||||||||||
| Due from related parties | |||||||||||||||||
| Tax advances and receivables | |||||||||||||||||
| Other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Non-current assets | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Operating lease assets | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Deferred tax asset, net | |||||||||||||||||
| Other non-current assets | |||||||||||||||||
| Total non-current assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities and stockholders' equity | |||||||||||||||||
| Current liabilities | |||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||
| Accrued payroll and employee-related liabilities | |||||||||||||||||
| Current deferred revenue | |||||||||||||||||
| Current operating lease liabilities | |||||||||||||||||
| Convertible debt | |||||||||||||||||
| Current debt | |||||||||||||||||
| Due to related parties | |||||||||||||||||
| Income taxes payable | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Non-current liabilities | |||||||||||||||||
| Non-current deferred revenue | |||||||||||||||||
| Non-current operating lease liabilities | |||||||||||||||||
| Long-term debt | |||||||||||||||||
| Other non-current liabilities | |||||||||||||||||
| Total non-current liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Stockholders' equity | |||||||||||||||||
| Common shares: par value $0.000111650536, 108,057,967 shares authorized, 13,308,978 and 13,309,640 shares outstanding as of September 30, 2026 and June 30, 2026, respectively | |||||||||||||||||
| Treasury shares at cost: 6,090,967 and 5,968,161 shares as of September 30, 2026 and June 30, 2026, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Retained earnings | |||||||||||||||||
| Total stockholders' equity | |||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||
Loading...